• Profile
Close

Predictive value of pretreatment lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio in the survival of nasopharyngeal carcinoma patients

Cancer Management and Research Nov 25, 2021

Chen Y, Sun J, Hu D, et al. - Survival in nasopharyngeal carcinoma (NPC) can be predicted by using the index lymphocyte-to-monocyte ratio (LMR) and platelet-to-lymphocyte ratio (PLR).

  • In this retrospective study of 216 patients with NPC, predictive value of some indexes in the survival of NPC was assessed; receiver operating characteristic curve was applied.

  • Poor overall survival (OS) was observed in relation to neutrophil-to-lymphocyte ratio (NLR) ≤ 2.695 and PLR ≤ 140.065; however, the LMR and systemic inflammatory response index (SIRI) displayed no significant statistical significance.

  • NLR ≤ 2.045 and PLR ≤ 125.605 were related to poor regional recurrence-free survival, LMR ≤ 2.535 and PLR ≤ 140.065 were linked with poor distant metastasis-free survival (DMFS), NLR ≤ 2.125 and PLR ≤ 132.645 were related to poor locoregional recurrence-free survival, respectively.

  • In logistic regression analysis, low LMR (≤ 2.535) was significantly inferior in OS (HR 23.085) and DMFS (HR 22.839).

  • Moreover, a significant association of low PLR (≤ 140.065) with worse OS (HR 11.908) and DMFS (HR 9.556) was found.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay